Can a simple symptom tracker improve life for dialysis patients?
NCT ID NCT05738330
First seen Dec 08, 2025 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This study tests whether a digital symptom tracking system (SMaRRT-HD) helps dialysis patients feel better by alerting their care team to issues. About 2,400 adults on hemodialysis at up to 36 U.S. clinics will either use the system or receive usual care for 12 months. The goal is to see if regular symptom reporting and follow-up reduces symptom burden and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fresenius Medical Care
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SMaRRT-HD symptom monitoring system (behavioral intervention)
What this could lead to
If successful, this could give dialysis clinics a practical tool to better manage patients' symptoms and improve quality of life.
What could go wrong
This is a behavioral study, not a drug or device. It may not show a clear benefit over usual care, and results depend on how well clinics adopt the system.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.